CN102465170A - A method for detecting single nucleotide polymorphism of BANK1 gene - Google Patents
A method for detecting single nucleotide polymorphism of BANK1 gene Download PDFInfo
- Publication number
- CN102465170A CN102465170A CN2010105335183A CN201010533518A CN102465170A CN 102465170 A CN102465170 A CN 102465170A CN 2010105335183 A CN2010105335183 A CN 2010105335183A CN 201010533518 A CN201010533518 A CN 201010533518A CN 102465170 A CN102465170 A CN 102465170A
- Authority
- CN
- China
- Prior art keywords
- single nucleotide
- nucleotide polymorphism
- primer
- gene
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 239000002773 nucleotide Substances 0.000 title claims abstract description 23
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 23
- 101100381461 Homo sapiens BANK1 gene Proteins 0.000 title abstract description 13
- 239000000523 sample Substances 0.000 claims abstract description 78
- 230000008018 melting Effects 0.000 claims abstract description 76
- 238000002844 melting Methods 0.000 claims abstract description 76
- 102210048083 rs17266594 Human genes 0.000 claims abstract description 27
- 102200015609 rs10516487 Human genes 0.000 claims abstract description 26
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims abstract description 17
- 238000001514 detection method Methods 0.000 claims abstract description 16
- 238000012408 PCR amplification Methods 0.000 claims abstract description 11
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 10
- 210000001124 body fluid Anatomy 0.000 claims abstract description 6
- 239000010839 body fluid Substances 0.000 claims abstract description 6
- 201000009594 Systemic Scleroderma Diseases 0.000 claims abstract description 4
- 206010042953 Systemic sclerosis Diseases 0.000 claims abstract description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims abstract description 4
- 239000000975 dye Substances 0.000 claims description 15
- 101150084750 1 gene Proteins 0.000 claims description 11
- 238000013461 design Methods 0.000 claims description 7
- 238000009738 saturating Methods 0.000 claims description 4
- 239000012503 blood component Substances 0.000 claims description 2
- 230000002996 emotional effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 14
- 101000971155 Homo sapiens B-cell scaffold protein with ankyrin repeats Proteins 0.000 abstract description 5
- 208000023275 Autoimmune disease Diseases 0.000 abstract description 3
- 229920006395 saturated elastomer Polymers 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 210000005259 peripheral blood Anatomy 0.000 abstract description 2
- 239000011886 peripheral blood Substances 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 22
- 230000008859 change Effects 0.000 description 12
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 108010032354 Inositol 1,4,5-Trisphosphate Receptors Proteins 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 102000007640 Inositol 1,4,5-Trisphosphate Receptors Human genes 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 210000003719 b-lymphocyte Anatomy 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 7
- 230000027455 binding Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 102100021568 B-cell scaffold protein with ankyrin repeats Human genes 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 108091008875 B cell receptors Proteins 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 238000007846 asymmetric PCR Methods 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 108010049777 Ankyrins Proteins 0.000 description 2
- 102000008102 Ankyrins Human genes 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 238000009004 PCR Kit Methods 0.000 description 2
- 101710184528 Scaffolding protein Proteins 0.000 description 2
- 101000832077 Xenopus laevis Dapper 1-A Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000019260 B-Cell Antigen Receptors Human genes 0.000 description 1
- 108010012919 B-Cell Antigen Receptors Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 101710204410 Scaffold protein Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 102000054766 genetic haplotypes Human genes 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000012642 immune effector Substances 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明属于基因工程和基因诊断领域,涉及BANK 1基因rs10516487和rs17266594位点单核苷酸多态性(SNP)的检测及用途。
The invention belongs to the field of genetic engineering and genetic diagnosis, and relates to the detection and application of single nucleotide polymorphisms (SNP) at rs10516487 and rs17266594 sites of
背景技术 Background technique
系统性红斑狼疮(SLE)是一种多系统受累的自身免疫性疾病,患者体内存在多种自身抗体。该病多发于女性,对人体的皮肤、肺部、血管和神经系统都可造成伤害。资料显示,若有SLE家族史,则SLE的发病率为一般人的数十倍。SLE也与人种、民族有关。如美国黑人女性的发病率远低于欧美一般人群,而在中国,SLE的发病率却比欧美国家高。可见这种疾病与遗传以及环境有关。目前认为可能由遗传、激素与环境等因素综合作用引起机体免疫调节功能紊乱、抗原抗体和补体复合物沉积导致局部或全身组织或器官损害。SLE患者常伴有显著的T、B淋巴细胞异常活化。B淋巴细胞作为经典的免疫效应细胞在SLE自身免疫过程中发挥了重要的作用。 Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems, and there are multiple autoantibodies in patients. The disease is more common in women and can cause damage to the skin, lungs, blood vessels and nervous system of the human body. Data show that if there is a family history of SLE, the incidence of SLE is dozens of times that of the general population. SLE is also related to race and ethnicity. For example, the incidence rate of black women in the United States is much lower than that of the general population in Europe and America, while in China, the incidence rate of SLE is higher than that in Europe and the United States. It can be seen that this disease is related to genetics and environment. At present, it is believed that the combination of factors such as genetics, hormones, and environment may cause immune regulation dysfunction, deposition of antigen, antibody, and complement complexes, and result in local or systemic tissue or organ damage. SLE patients are often accompanied by significant abnormal activation of T and B lymphocytes. B lymphocytes, as classic immune effector cells, play an important role in the process of SLE autoimmunity. the
B细胞支架蛋白上的锚蛋白重复序列1,简称BANK 1(B-cell scaffold protein with ankyrin repeats 1)。支架蛋白是一种在调节信号传导中起着重要作用的蛋白质,它通过辅助蛋白激酶和磷酸酶与他们各自的底物结合而起作用。锚蛋白重复序列(ANK)是生物体中广泛利用的一种序列模体。ANK结构域介导蛋白质与蛋白质的相互作用,它能够和多种配体结合,从而实现纷繁复杂的生物功能。BANK 1基因编码的B细胞特异性支架蛋白,在B细胞受体诱导胞内钙离子动员中起着重要作用。同时也可促进Lyn(一种主要在造血细胞中表达的膜结合蛋白酪氨酸激酶)介导的1,4,5-三磷酸肌醇受体(IP3R)发生酪氨酸磷酸化。IP3R是一种化学门控的钙释放通道。钙离子通过IP3R通道从内质网释放入胞浆。IP3R被激活后可导致内质网或肌质网中Ca2+ 释放和胞质中Ca2+浓度升高。随后通过NFAT等多条信号途径使B细胞抗原受体信号通路活化,导致B细胞免疫耐受的丧失,引起B细胞反应性异常增高。
2008年Kozyrev等[1]首次发表了关于BANK 1与SLE易感性的报道。他们的研究发现,BANK 1是SLE的易感基因,而且BANK 1上的两个SNP位点,rs10516487和rs17266594与SLE的发病关系密切。Chang等[2]对中国香港地区人群的调查也证实了这一发现。
In 2008, Kozyrev et al [1] first published a report on the relationship between
rs10516487位于连结IP3R的关键区域[1],是一个非同义替代的SNP位点。同义替代仅改变密码子但不改变所翻译蛋白质的氨基酸序列,一般认为它不影响蛋白质结构和功能。而非同义替代的密码子变异可导致所编码氨基酸的改变,从而影响蛋白质的生理功能。这种变异常常是导致生物性状改变的直接原因。rs10516487的第61位氨基酸就是由精氨酸变为组氨酸。 rs10516487 is located in the key region linking IP3R [1] , which is a non-synonymous alternative SNP site. Synonymous substitution only changes the codon but does not change the amino acid sequence of the translated protein, and it is generally believed that it does not affect protein structure and function. Codon variations that are not synonymous substitutions can lead to changes in the encoded amino acids, thereby affecting the physiological function of the protein. This variation is often the direct cause of changes in biological traits. The 61st amino acid of rs10516487 is changed from arginine to histidine.
研究发现[1],BANK1存在一长一短两种亚型。短的亚型名为△2亚型,意指BANK1基因2号外显子全部缺失,导致其翻译生成的蛋白质缺少了IP3R结合区域。rs17266594恰好位于该序列分支点上(图1),其T等位基因的纯合子具有非常典型的分支点顺序(YNYTGAYYN)(Y:嘧啶,N表示任何核苷酸)。分支点顺序是位于核mRNA 内含子和Ⅱ类内含子3’端附近的保守序列。内含子的序列分支点、内含子的5’-端剪接点(供位)以及3’-端剪接点(受位)是mRNA前体正确剪接所必需的。因此,rs17266594的多态性直接关系到BANK 1基因△2亚型的剪接效率。
Studies have found that [1] , BANK1 has two isoforms, one long and one short. The short subtype is called △2 subtype, which means that the
rs10516487和rs17266594的多态性可能会影响到BANK 1基因的功能,从而通过一系列反应促使B细胞受体持续释放信号,导致B细胞过度活化。
The polymorphisms of rs10516487 and rs17266594 may affect the function of the
目前,筛查已知SNP常用检测方法有限制性酶切片段长度多态性(RFLP)、单链构象多态性(SSCP)、等位基因特异寡核苷酸片段分析(ASO)、变性梯度凝胶电泳法(DGGE)、Taqman探针法、基因芯片、测序等多种技术。但各有缺点,如RFLP仅能检测有酶切位点的 SNP,无酶切位点不能检测;RFLP、SSCP、ASO、DGGE都要用到电泳方法,灵敏度有限,对环境有污染;Taqman探针法价格昂贵;基因芯片不适宜多样本、少数SNP位点的检测;测序虽然是核苷酸检测的金标准,但成本较高,周期长,不适合大样本的疾病关联分析。 Currently, common detection methods for screening known SNPs include restriction fragment length polymorphism (RFLP), single-strand conformation polymorphism (SSCP), allele-specific oligonucleotide fragment analysis (ASO), denaturing gradient Gel electrophoresis (DGGE), Taqman probe method, gene chip, sequencing and other technologies. However, each has its own disadvantages. For example, RFLP can only detect SNPs with enzyme cleavage sites, but cannot detect SNPs without enzyme cleavage sites; RFLP, SSCP, ASO, and DGGE all use electrophoresis methods, which have limited sensitivity and pollute the environment; Acupuncture is expensive; gene chips are not suitable for the detection of multiple samples and a small number of SNP sites; although sequencing is the gold standard for nucleotide detection, it is expensive and takes a long time, so it is not suitable for disease association analysis of large samples.
采用高分辨率熔解法(High-resolution melting,HRM)检测SNP是近年来新推出的一种方法。它根据熔解温度(Tm)判断产物的性质。熔解温度由PCR产物的GC含量、长度、序列和杂合情况决定。结合了新型的饱和染料(如SYTO 9)和具有高分辨率的PCR仪(如Rotor-Gene 6000),即使只有一个碱基的改变,也可以从熔解温度上体现出来[3]。只需一种染料就可以满足任何目的基因的检测。但是如果在一个样本中同时存在多个突变,仅靠以上方法是不能判断的。或者当DNA样本纯度不高,PCR扩增出现引物二聚体时,会改变HRM检测到的熔解温度,从而影响结果的判断。因此,Taqman探针法虽然价格较贵,且受到每个荧光探针仅能针对一个检测靶位等多种限制,却依然广泛被临床采用[4]。对于大规模样本的检测,为了降低成本,迫切需要一种同时结合了探针的特异性和染料的普遍性的分析方法。未标记探针高分辨率熔解法(unlabeled probe high resolution melting,unlabeled probe HRM)完全符合了这些要求。 SNP detection using high-resolution melting method (High-resolution melting, HRM) is a new method introduced in recent years. It judges the nature of the product based on the melting temperature (Tm). The melting temperature is determined by the GC content, length, sequence, and heterozygosity of the PCR product. Combining a new type of saturating dye (such as SYTO 9) and a high-resolution PCR instrument (such as Rotor-Gene 6000), even if there is only one base change, it can be reflected from the melting temperature [3] . Only one dye is needed for the detection of any target gene. However, if there are multiple mutations in a sample at the same time, it cannot be judged by the above method alone. Or when the purity of the DNA sample is not high and primer dimers appear in PCR amplification, it will change the melting temperature detected by HRM, thereby affecting the judgment of the result. Therefore, although the Taqman probe method is more expensive and is subject to various limitations such as each fluorescent probe can only target one detection target, it is still widely used clinically [4] . For the detection of large-scale samples, in order to reduce the cost, an analytical method that combines the specificity of probes and the universality of dyes is urgently needed. Unlabeled probe high resolution melting (unlabeled probe high resolution melting, unlabeled probe HRM) fully meets these requirements.
未标记探针法在PCR的基础上作了进一步改进:3’端封闭的未标记探针、染料以及一对浓度不一致的引物。SYBR Green I作为一种经典的染料在PCR中已经沿用了十几年。不过由于这是一种不饱和染料,不能完全填满DNA双链的小沟,在DNA解链的过程中游离下来的SYBR Green I会重新结合到未解链的双链中,造成结果失真。过量的SYBR Green I还会抑制PCR扩增。在未标记探针法中,适合PCR扩增的SYBR Green I浓度仅能检测到熔解温度较高的产物,无法判断异源双链的存在[5]。 The unlabeled probe method is further improved on the basis of PCR: 3'-end blocked unlabeled probe, dye and a pair of primers with inconsistent concentrations. SYBR Green I has been used as a classic dye in PCR for more than ten years. However, since this is an unsaturated dye, it cannot completely fill the minor groove of the DNA double strand, and the dissociated SYBR Green I during the melting of the DNA will recombine into the unmelted double strand, resulting in distortion of the results. Excess SYBR Green I also inhibits PCR amplification. In the unlabeled probe method, the concentration of SYBR Green I suitable for PCR amplification can only detect products with higher melting temperatures, and cannot determine the existence of heteroduplexes [5] .
参考文献: references:
1. Kozyrev SV, Abelson AK,Wojcik J, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat genet, 2008, 40: 211-216. 1. Kozyrev SV, Abelson AK, Wojcik J, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat genet, 2008, 40: 211-216.
2. Chang YK, Yang W, Zhao M, et al. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun, 2009, 10: 414-420. 2. Chang YK, Yang W, Zhao M, et al. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun, 2009, 10: 414-420.
3. Reed GH, Kent JO, Wittwer CT. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics,2007,8: 597-608. 3. Reed GH, Kent JO, Wittwer CT. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics, 2007, 8: 597-608.
4. Erali M, Palais R, Wittwer C. SNP genotyping by unlabeled probe melting Analysis. Methods Mol Biol, 2008, 429:199-206. 4. Erali M, Palais R, Wittwer C. SNP genotyping by unlabeled probe melting Analysis. Methods Mol Biol, 2008, 429:199-206.
5. Zhou L, Myers AN, Vandersteen JG,et al. Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem, 2004, 50, 1328-1335. 5. Zhou L, Myers AN, Vandersteen JG, et al. Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem, 2004, 50, 1328-1335.
发明内容 Contents of the invention
本发明的目的是提供一种简易的检测BANK1基因多态性的方法。该方法具有快速、简单、无污染的特点,可检测各类标本,包括血清(浆)和各种体液。 The purpose of the present invention is to provide a simple method for detecting the polymorphism of BANK1 gene. The method is fast, simple, and non-polluting, and can detect various specimens, including serum (serum) and various body fluids.
本发明的另一个目的是提供一种简易的检测BANK1基因多态性的试剂盒。 Another object of the present invention is to provide a simple kit for detecting polymorphism of BANK1 gene.
the
未标记探针HRM中,不对称PCR反应里的未标记探针由于3’端已经封闭,不会在聚合酶的作用下扩增。依靠上、下游引物可以扩增出大量的相互配对的目的片断,当一条引物耗尽后,另一条过量引物会继续扩增DNA单链,游离的探针与这些单链结合。探针与不对称PCR扩增出的单链产物结合,饱和染料结合到探针/产物以及产物/产物结合形成的双链中。饱和染料(如SYTO 9,LC Green)具有更强的DNA结合能力和很低的抑制作用,完全适用于对单个碱基改变的检测。 In the unlabeled probe HRM, the unlabeled probe in the asymmetric PCR reaction will not be amplified under the action of the polymerase because the 3' end has been blocked. Relying on the upstream and downstream primers, a large number of paired target fragments can be amplified. When one primer is exhausted, the other excess primer will continue to amplify DNA single strands, and free probes will bind to these single strands. The probe binds to the single-stranded product amplified by asymmetric PCR, and the saturating dye binds to the duplex formed by the probe/product and product/product combination. Saturating dyes (such as SYTO 9, LC Green) have stronger DNA binding ability and low inhibition, which are completely suitable for the detection of single base changes.
产物若是含有不同的等位基因,则其与探针形成的双链的熔解温度会显示出明显的差异。产物之间的相互配对同样如此。通过高分辨率仪器自带的软件分析后,可以清晰地显示出不同基因型。 If the product contains different alleles, the melting temperature of the duplex formed with the probe will show a significant difference. The same goes for mutual pairings between products. After analysis by the software that comes with the high-resolution instrument, different genotypes can be clearly displayed.
在荧光的负导数图(-dF/ dT)中,每个样本至少会出现2个熔解峰,一个是熔解温度较低的探针/产物的熔解峰,另一个则是熔解温度较高的产物/产物的熔解峰。若扩增片段内还含有其他未知碱基突变,则除上述2个外,还会出现第3个熔解峰。 In the negative derivative plot of fluorescence (-dF/dT), there will be at least 2 melting peaks for each sample, one is the melting peak of the probe/product with a lower melting temperature, and the other is the product with a higher melting temperature / Melting peak of the product. If the amplified fragment contains other unknown base mutations, in addition to the above two, a third melting peak will appear.
在熔解温度较低的探针/产物的熔解峰中,若由模板DNA扩增出的单链产物与探针完全匹配,由于需要较高的能量才能使双链解链,熔解温度会较高;若待测模板DNA中的SNP位点与探针不完全匹配,只需较低的能量即可打开双链结构,因此熔解温度较低;若模板DNA为杂合子,则其熔解曲线会同时具有上述2种熔解峰的特征。 In the melting peak of the probe/product with a lower melting temperature, if the single-stranded product amplified from the template DNA completely matches the probe, the melting temperature will be higher due to the need for higher energy to melt the double-strand ; If the SNP site in the template DNA to be tested does not completely match the probe, only low energy can be used to open the double-stranded structure, so the melting temperature is low; if the template DNA is heterozygous, its melting curve will be simultaneously It has the characteristics of the above two melting peaks.
在熔解温度较高的产物/产物的熔解峰中,当扩增片段内除待测位点外无其他碱基改变时,产物/产物的熔解峰与探针/产物的熔解峰结果一致;当扩增片段内还含有其他位点的碱基改变时,则产物/产物的熔解峰形态会改变,提示存在其他碱基改变。由于不同碱基间产物/产物熔解峰的差异一般<0.5℃,因此通过软件将数据转换成普通视图进行局部放大后更易观察这类碱基改变。在DNA的双螺旋结构中,G-C碱基对有3对氢键,A-T碱基对有2对氢键,因此破坏G-C间氢键需比A-T氢键付出更多的能量,故CC/GG基因型的熔解温度比TT/AA基因型高,而杂合子由于结合不牢固,熔解温度更低。 In the melting peak of the product/product with a higher melting temperature, when there is no other base change in the amplified fragment except the site to be detected, the melting peak of the product/product is consistent with the melting peak of the probe/product; when When the amplified fragment also contains base changes at other sites, the shape of the product/melting peak of the product will change, suggesting that there are other base changes. Since the difference between product/product melting peaks between different bases is generally <0.5°C, it is easier to observe such base changes after converting the data into a normal view by software for partial zoom-in. In the double helix structure of DNA, G-C base pairs have 3 pairs of hydrogen bonds, and A-T base pairs have 2 pairs of hydrogen bonds. Therefore, it takes more energy to destroy the hydrogen bonds between G-C than A-T hydrogen bonds. Therefore, the CC/GG gene The melting temperature of the genotype is higher than that of the TT/AA genotype, while the heterozygote has a lower melting temperature due to weak combination. the
通过结合荧光导数图和普通视图的结果,可以准确的判断出BANK1基因多态性位点的基因型。 By combining the results of the fluorescence derivative graph and the normal view, the genotype of the polymorphic site of the BANK1 gene can be accurately judged.
the
本发明提供了一种检测BANK 1基因单核苷酸多态性的方法,该方法依次包括:设计扩增单核苷酸多态性位点序列的引物和探针;以样本DNA为模板,利用上述引物和探针进行PCR扩增;加入饱和染料;分析熔解度曲线,确定单核苷酸多态性。探针按照单核苷酸多态性位点序列设计。引物按照PCR原理设计,通过后续PCR结果确定。
The invention provides a method for detecting the single nucleotide polymorphism of the
进行PCR扩增的引物中的上游引物和下游引物浓度不同,一种不小于另一种的浓度的5倍。例如,下游引物浓度是上游引物10倍,15倍,20倍,25倍,30倍,等。 Among the primers for PCR amplification, the concentrations of the upstream primer and the downstream primer are different, and the concentration of one is not less than 5 times that of the other. For example, the concentration of the downstream primer is 10 times, 15 times, 20 times, 25 times, 30 times, etc. of the upstream primer.
所述的样本是血液成分或者体液。 Said sample is blood component or body fluid.
所述的饱和染料是SYTO 9或者LC Green(市售,例如Invitrogen公司,美国)。 The saturated dye is SYTO 9 or LC Green (commercially available, such as Invitrogen, USA).
探针浓度不小于两种引物的浓度差。探针浓度也可以略小于上游和下游引物的浓度差,或者探针浓度等同于浓度高的那个引物。 The probe concentration is not less than the concentration difference of the two primers. The probe concentration can also be slightly less than the difference between the concentrations of the upstream and downstream primers, or the probe concentration can be equal to the one with the higher concentration.
在本发明的一个实施例中,所述的单核苷酸多态性的位点是rs10516487。所述的引物序列如 SEQ ID NO 1和SEQ ID NO 2所示,所述的探针序列如SEQ ID NO 3所示。
In one embodiment of the present invention, the site of the single nucleotide polymorphism is rs10516487. The primer sequence is shown in
在本发明的另一个实施例中,所述的单核苷酸多态性的位点是rs17266594。所述的引物序列如 SEQ ID NO 4和SEQ ID NO 5所示,所述的探针序列如SEQ ID NO 6所示。
In another embodiment of the present invention, the site of the single nucleotide polymorphism is rs17266594. The primer sequence is shown in SEQ ID NO 4 and
具体而言,本方法从样本中抽提DNA后,采用添加了未标记探针的不对称聚合酶链式反应(PCR)扩增出需要的DNA片断,加入饱和荧光染料,随着温度的下降检测其荧光变化。每个样本有2个熔解峰,温度较低的熔解峰用于判断探针覆盖范围内的碱基变化,温度较高的熔解峰用于判断整个目的片断内碱基变化。 Specifically, after the DNA is extracted from the sample in this method, the required DNA fragments are amplified by asymmetric polymerase chain reaction (PCR) with the addition of unlabeled probes, and saturated fluorescent dyes are added. Detect its fluorescence change. Each sample has 2 melting peaks, the melting peak with a lower temperature is used to judge the base change within the coverage of the probe, and the melting peak with a higher temperature is used to judge the base change in the entire target fragment.
1. 从血浆中抽提DNA。 1. DNA extraction from plasma.
2. 设计引物。 2. Design primers.
3. 设计针对待测位点的探针,不标记荧光,3’端用C3封闭。 3. Design a probe for the site to be tested, without fluorescent labeling, and block the 3' end with C3.
4. 加入荧光染料,如SYTO 9进行不对称PCR扩增。结束后,在高分辨率PCR仪上检测熔解温度,分析温度下降时样本荧光信号的变化。 4. Add fluorescent dyes, such as SYTO 9, for asymmetric PCR amplification. After the end, the melting temperature is detected on a high-resolution PCR instrument, and the change of the fluorescent signal of the sample is analyzed when the temperature drops.
5. 分析待测样本BANK1基因rs10516487和rs17266594多态性。 5. Analyze the rs10516487 and rs17266594 polymorphisms of the BANK1 gene in the sample to be tested.
相应的,本发明提供了一种检测BANK 1基因单核苷酸多态性的试剂盒,该试剂盒包括扩增单核苷酸多态性位点序列的引物和探针。还可以包括饱和染料,缓冲液等。
Correspondingly, the present invention provides a kit for detecting the single nucleotide polymorphism of the
发明的检测BANK 1基因单核苷酸多态性方法,可以用于预测患系统性红斑狼疮、类风湿性关节炎或者系统性硬皮病的易感性。
The invented method for detecting the single nucleotide polymorphism of the
BANK1基因rs10516487和rs17266594 两个位点均为SLE 的易感位点,携带CT单倍型的人群患SLE的概率为正常人的1.6倍,可用于评估个体患上该疾病的风险性。 Both BANK1 gene rs10516487 and rs17266594 loci are susceptibility loci for SLE, and the probability of SLE in people carrying the CT haplotype is 1.6 times that of normal people, which can be used to assess the risk of individuals suffering from the disease. the
BANK1的△2亚型,意指BANK1基因2号外显子全部缺失,其翻译获得的蛋白缺失IP3R结合区。rs17266594恰好位于BANK1该序列分支点上。因此,rs17266594的多态性直接关系到BANK 1基因的剪接效率和翻译获得蛋白的功能。rs10516487位于连结IP3R的关键区域,是一个非同义替代的SNP位点。rs10516487和rs17266594的多态性会影响到BANK 1基因的功能,从而通过一系列反应促使B细胞受体持续释放信号,导致B细胞过度活化。
The Δ2 subtype of BANK1 means that
the
本发明提供了一种检测BANK 1基因单核苷酸多态性的方法,可采用该方法检测外周血或体液中BANK1基因rs10516487和rs17266594多态性。以判断罹患系统性红斑狼疮、类风湿性关节炎、系统性硬皮病等自身免疫性疾病的可能性。该方法操作具有快速、简单、无污染的特点,检测结果分辨率高,可检测各类标本,包括血清(浆)和各种体液。本发明还提供了相应的检测试剂盒。 The invention provides a method for detecting the single nucleotide polymorphism of the BANK1 gene, which can be used to detect the rs10516487 and rs17266594 polymorphisms of the BANK1 gene in peripheral blood or body fluid. To determine the possibility of suffering from systemic lupus erythematosus, rheumatoid arthritis, systemic scleroderma and other autoimmune diseases. The operation of this method has the characteristics of fast, simple and pollution-free, and the detection result has high resolution, and can detect various specimens, including serum (serum) and various body fluids. The invention also provides a corresponding detection kit.
附图说明 Description of drawings
图1:rs10516487和rs17266594位点示意图。rs10516487是一个非同义替代的SNP位点,导致第61位氨基酸由精氨酸变为组氨酸;rs17266594位于序列分支点上,具有典型的分支点顺序。 Figure 1: Schematic diagram of rs10516487 and rs17266594 loci. rs10516487 is a non-synonymous substitution SNP site, which leads to the change of amino acid 61 from arginine to histidine; rs17266594 is located at the branch point of the sequence and has a typical sequence of branch points.
图2:rs10516487位点的荧光负导数图(-dF/ dT)。左侧为熔解温度较低的探针/产物的熔解峰,右侧为熔解温度较高的产物/产物的熔解峰。红线代表CC基因型,蓝线代表CT基因型,黄线代表TT基因型。 Figure 2: Negative fluorescence derivative plot (-dF/dT) of the rs10516487 locus. On the left is the melting peak of the probe/product with a lower melting temperature, and on the right is the melting peak of the product/product with a higher melting temperature. The red line represents the CC genotype, the blue line represents the CT genotype, and the yellow line represents the TT genotype.
图3:rs10516487位点产物/产物熔解曲线的普通视图。红线代表CC基因型,蓝线代表CT基因型,黄线代表TT基因型。 Figure 3: Generic view of the product/product melting curve for the rs10516487 site. The red line represents the CC genotype, the blue line represents the CT genotype, and the yellow line represents the TT genotype.
图4:rs17266594位点的荧光负导数图(-dF/ dT)。左侧为熔解温度较低的探针/产物的熔解峰,右侧为熔解温度较高的产物/产物的熔解峰。红线代表TT基因型,蓝线代表TC基因型,黄线代表CC基因型。 Figure 4: Negative fluorescence derivative plot (-dF/dT) of the rs17266594 locus. On the left is the melting peak of the probe/product with a lower melting temperature, and on the right is the melting peak of the product/product with a higher melting temperature. The red line represents the TT genotype, the blue line represents the TC genotype, and the yellow line represents the CC genotype.
图5:rs17266594位点产物/产物熔解曲线的普通视图。红线代表TT基因型,蓝线代表TC基因型,黄线代表CC基因型。 Figure 5: Generic view of the product/product melting curve for the rs17266594 site. The red line represents the TT genotype, the blue line represents the TC genotype, and the yellow line represents the CC genotype.
具体实施方式 Detailed ways
实施例1:rs10516487位点多态性检测 Example 1: Detection of polymorphism at rs10516487
1. DNA提取: 1. DNA extraction:
使用乙二胺四乙酸(EDTA)抗凝的真空采血管采集静脉血2ml,使用QIAamp DNA Extract Kit(德国Qiagen公司)试剂盒提取DNA。 2 ml of venous blood was collected using ethylenediaminetetraacetic acid (EDTA) anticoagulated vacuum blood collection tubes, and DNA was extracted using the QIAamp DNA Extract Kit (Qiagen, Germany) kit.
2. 引物设计: 2. Primer design:
使用Primer 3 软件(http://frodo.wi.mit.edu/)设计引物,经过人工筛选和PCR实验验证,获得引物。rs10516487的上游引物F:5’- ACATTTGTAAGACGTTAAGTTCAGCA-3’ (SEQ ID NO 1),下游引物R: 5’-ATGATATATGAAGAAGATGCTGAGGA-3’ (SEQ ID NO 2),扩增片段长度150 bp。引物由上海生工生物工程技术服务有限公司合成。
Primers were designed using
3. 探针设计: 3. Probe design:
使用Primer Premier 5.0软件设计探针,rs10516487的探针为5’-GAAAAGAGAAATTCTCCAAGCGATATAACAGGATG-3’ (SEQ ID NO 3),探针由上海生工生物工程技术服务有限公司合成,3’端作C3封闭,防止探针延伸。 The probe was designed using Primer Premier 5.0 software. The probe of rs10516487 was 5'-GAAAAGAGAAATTCTCCAAGCGATATAACAGGATG-3' (SEQ ID NO 3). Probe extension.
4. 样本检测: 4. Sample testing:
使用TaKaRa PCR试剂盒(宝生物,日本)进行PCR扩增。反应体系包括:0.1 l TaKaRa Taq HS(5 U/ μl),2 l 10 × PCR Buffer (-) (Mg2+ Free),1.2 l MgCl2(25 mM),1.6 l dNTP Mixture(各2.5 mM),上游引物F 1 l(1M),下游引物R 1 l(10M),探针1 l(10M),加水至总体积19.3 l,然后加入0.7 l样本DNA。PCR扩增条件:95℃ 2 min,94℃ 30 s、58℃ 30 s、72℃ 30 s,50个循环后,72℃ 5 min延伸。使用Eppendorf personal 基因扩增仪(Eppendorf公司,德国)扩增后加入0.7 l SYTO 9 染料(50 M)(Invitrogen公司,美国),再将样品管转移到Rotor-Gene 6000(Mortlake Corbett Research公司,澳大利亚),进行高分辨率熔解分析。条件为:95°C 2 min,25°C 2 min预处理后,熔解温度从55°C升至88°C,每升高0.2 °C采集一次数据,获得高分辨率熔解曲线图。
PCR amplification was performed using TaKaRa PCR kit (Takara Bio, Japan). The reaction system includes: 0.1 l TaKaRa Taq HS (5 U/μl), 2
5. 多态性分析 5. Polymorphism analysis
在荧光的负导数图(-dF/ dT)中,位于左侧的是熔解温度较低的探针/产物的熔解峰。若模板DNA 的rs10516487位点碱基为胞嘧啶(C),则扩增出的单链产物与探针完全匹配,熔解温度较高,熔解峰偏右;若模板DNA 的该位点碱基为胸腺嘧啶(T),则单链无法与探针完全匹配,熔解温度较低,熔解峰偏左;若模板DNA为杂合子,该位点碱基部分为C,部分为T,则其熔解曲线会同时具有上述2种熔解峰的特征(图2)。 On the plot of the negative derivative of fluorescence (-dF/dT), on the left is the melting peak of the lower melting probe/product. If the rs10516487 base of the template DNA is cytosine (C), the amplified single-stranded product will completely match the probe, the melting temperature will be higher, and the melting peak will be to the right; if the base of the template DNA is Thymine (T), the single strand cannot completely match the probe, the melting temperature is low, and the melting peak is left; It will have the characteristics of the above two melting peaks at the same time (Figure 2).
位于右侧的是熔解温度较高的产物/产物的熔解峰。通过软件将数据转换成普通视图,将产物/产物的熔解曲线局部放大后观察碱基改变。rs10516487位点的CC基因型Tm最高,位于右侧,TT基因型其次,而CT基因型由于结合不牢固,Tm最低(图3)。 On the right is the melting peak of the higher melting temperature product/product. The data is converted into a normal view through the software, and the melting curve of the product/product is partially enlarged to observe the base change. The Tm of the CC genotype at the rs10516487 locus is the highest, located on the right, followed by the TT genotype, while the CT genotype has the lowest Tm due to weak binding (Figure 3). the
通过结合荧光导数图和普通视图的结果,可以准确判断出BANK1基因rs10516487位点的基因型。 By combining the results of the fluorescence derivative map and the normal view, the genotype of the rs10516487 site of the BANK1 gene can be accurately determined.
the
实施例2 rs17266594位点多态性检测 Example 2 rs17266594 site polymorphism detection
1. DNA提取: 1. DNA extraction:
使用乙二胺四乙酸(EDTA)抗凝的真空采血管采集静脉血2ml,使用QIAamp DNA Extract Kit(德国Qiagen公司)试剂盒提取DNA。 2 ml of venous blood was collected using ethylenediaminetetraacetic acid (EDTA) anticoagulated vacuum blood collection tubes, and DNA was extracted using the QIAamp DNA Extract Kit (Qiagen, Germany) kit.
2. 引物设计: 2. Primer design:
使用Primer 3 软件(http://frodo.wi.mit.edu/)设计引物,经过人工筛选和PCR实验验证,获得引物。rs17266594的上游引物F:5’-AGGACTTTCATAGAGTTTTTCTCTGG-3’ (SEQ ID NO 4),下游引物R:5’- CATTCCTCAGCATCTTCTTCA-3’ (SEQ ID NO 5),扩增片段长度185 bp。引物由上海生工生物工程技术服务有限公司合成。
Primers were designed using
3. 探针设计: 3. Probe design:
使用Primer Premier 5.0软件设计探针,rs17266594的探针为5’-TAATAATTTAACCTGCTGATAGCATTGCAAATAT-3(SEQ ID NO 6)。探针由上海生工生物工程技术服务有限公司合成,3’端作C3封闭,防止探针延伸。 The probe was designed using Primer Premier 5.0 software, and the probe of rs17266594 was 5'-TAATAATTTAACCTGCTGATAGCATTGCAAATAT-3 (SEQ ID NO 6). The probe was synthesized by Shanghai Sangon Bioengineering Technology Service Co., Ltd., and the 3' end was blocked by C3 to prevent the probe from extending.
4. 样本检测: 4. Sample testing:
使用TaKaRa PCR试剂盒(宝生物,日本)进行PCR扩增。反应体系包括:0.1 l TaKaRa Taq HS(5 U/ μl),2 l 10 × PCR Buffer (-) (Mg2+ Free),1.2 l MgCl2(25 mM),1.6 l dNTP Mixture(各2.5 mM),上游引物F 1 l(0.67M),下游引物R 1 l(10M),探针1.5 l(10M),加水至总体积19.3 l,然后加入0.7 l样本DNA。PCR扩增条件:95℃ 2 min,94℃ 30 s、58℃ 30 s、72℃ 30 s,50个循环后,72℃ 5 min延伸。使用Eppendorf personal 基因扩增仪(Eppendorf公司,德国)扩增后加入0.7 l SYTO 9 染料(50 M)(Invitrogen公司,美国),再将样品管转移到Rotor-Gene 6000(Mortlake Corbett Research公司,澳大利亚),进行高分辨率熔解分析。条件为:95°C 2 min,40°C 2 min预处理后,熔解温度从57°C升至83°C,每升高0.2 °C采集一次数据,获得高分辨率熔解曲线图。
PCR amplification was performed using TaKaRa PCR kit (Takara Bio, Japan). The reaction system includes: 0.1 l TaKaRa Taq HS (5 U/μl), 2
5. 多态性分析 5. Polymorphism analysis
在荧光的负导数图(-dF/ dT)中,位于左侧的是熔解温度较低的探针/产物的熔解峰。若模板DNA 的rs17266594位点碱基为胸腺嘧啶(T),则扩增出的单链产物与探针完全匹配,熔解温度较高,熔解峰偏右;若模板DNA 的该位点碱基为胞嘧啶(C),则单链无法与探针完全匹配,熔解温度较低,熔解峰偏左;若模板DNA为杂合子,该位点碱基部分为T,部分为C,则其熔解曲线会同时具有上述2种熔解峰的特征(图4)。 On the plot of the negative derivative of fluorescence (-dF/dT), on the left is the melting peak of the lower melting probe/product. If the rs17266594 base of the template DNA is thymine (T), the amplified single-stranded product matches the probe completely, the melting temperature is higher, and the melting peak is to the right; if the base of the template DNA is Cytosine (C), the single strand cannot be completely matched with the probe, the melting temperature is low, and the melting peak is to the left; if the template DNA is heterozygous, part of the base at this site is T, and part of it is C, the melting curve It will have the characteristics of the above two melting peaks at the same time (Figure 4).
位于右侧的是熔解温度较高的产物/产物的熔解峰。通过软件将数据转换成普通视图,将产物/产物的熔解曲线局部放大后观察碱基改变。rs17266594位点的CC基因型Tm最高,位于右侧,TT基因型其次,而TC基因型由于结合不牢固,Tm最低(图5)。 On the right is the melting peak of the higher melting temperature product/product. The data is converted into a normal view through the software, and the melting curve of the product/product is partially enlarged to observe the base change. The Tm of the CC genotype at the rs17266594 locus is the highest, located on the right, followed by the TT genotype, and the Tm of the TC genotype is the lowest due to weak binding (Figure 5). the
通过结合荧光导数图和普通视图的结果,可以准确判断出BANK1基因rs17266594位点的基因型。 By combining the results of the fluorescence derivative graph and the normal view, the genotype of the rs17266594 locus of the BANK1 gene can be accurately determined.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105335183A CN102465170A (en) | 2010-11-05 | 2010-11-05 | A method for detecting single nucleotide polymorphism of BANK1 gene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105335183A CN102465170A (en) | 2010-11-05 | 2010-11-05 | A method for detecting single nucleotide polymorphism of BANK1 gene |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102465170A true CN102465170A (en) | 2012-05-23 |
Family
ID=46069290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105335183A Pending CN102465170A (en) | 2010-11-05 | 2010-11-05 | A method for detecting single nucleotide polymorphism of BANK1 gene |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102465170A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110452803A (en) * | 2019-08-27 | 2019-11-15 | 东南大学 | A kind of nucleic acid rapid amplification detection method and device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100099101A1 (en) * | 2008-09-26 | 2010-04-22 | Genentech, Inc. | Methods for treating, diagnosing, and monitoring lupus |
-
2010
- 2010-11-05 CN CN2010105335183A patent/CN102465170A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100099101A1 (en) * | 2008-09-26 | 2010-04-22 | Genentech, Inc. | Methods for treating, diagnosing, and monitoring lupus |
Non-Patent Citations (3)
Title |
---|
KOZYREV 等: "Functional variants in the B-cell gene BANK1 are associated with systemic lupus erthematosus", 《NATURE GENETICS》, vol. 40, no. 2, 29 February 2008 (2008-02-29), pages 211 - 215, XP002478892 * |
张鑫: "PXK基因多态性与汉族人系统性红斑狼疮易感性关联分析", 《中国优秀硕士学位论文全文数据库》, no. 4, 15 April 2010 (2010-04-15), pages 065 - 89 * |
郜莉娜: "无标记探针检测单核苷酸多态性分子诊断技术的建立和应用", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》, no. 7, 15 July 2010 (2010-07-15), pages 060 - 35 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110452803A (en) * | 2019-08-27 | 2019-11-15 | 东南大学 | A kind of nucleic acid rapid amplification detection method and device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5307538B2 (en) | UGT1A1 gene amplification primer set, UGT1A1 gene amplification reagent containing the same, and use thereof | |
WO2013056651A1 (en) | Method and probe for gene variation detection based on non-diagnostic purpose of fluorescence quenching | |
CN103205488B (en) | Method and reagent for prediction of ankylosing spondylitis susceptibility | |
JPWO2008117782A1 (en) | Gene amplification primer set, gene amplification reagent containing the same, and use thereof | |
WO2011062258A1 (en) | Primer set for amplification of mthfr gene, mthfr gene amplification reagent comprising same, and use of same | |
CN104894230A (en) | Group-specific primer PCR-SBT method and reagent based on HLA-DQB1 genetic typing | |
JP5279492B2 (en) | Obesity gene amplification primer set, obesity gene amplification reagent containing the same, and use thereof | |
JPWO2008066163A1 (en) | CYP2C9 gene amplification primer set, CYP2C9 gene amplification reagent containing the same, and use thereof | |
CN104774918A (en) | IL28B gene polymorphism detection kit based on real-time fluorescent PCR | |
JP6153515B2 (en) | Method for detecting HLA-A * 24: 02 and detection kit | |
CN106636365B (en) | Nucleic acid, kit and method for detecting A1166C polymorphic site of AGTR1 gene | |
CN102465170A (en) | A method for detecting single nucleotide polymorphism of BANK1 gene | |
MX2015003386A (en) | Method for detection of braf and pi 3k mutations. | |
CN103710448B (en) | Method and kit for predicting susceptibility of ankylosing spondylitis | |
CN103710447B (en) | Method and reagent for predicting susceptibility of ankylosing spondylitis | |
CN108410966B (en) | Method for detecting insertion and deletion of ACE gene | |
JP7335871B2 (en) | Multiplex detection of short nucleic acids | |
CN103060330B (en) | Kit for predicting susceptibility to prostate cancer | |
CN103882113B (en) | Kit for predicting susceptibility of ankylosing spondylitis | |
CN103695549B (en) | Agent for predicting susceptibility to ankylosing spondylitis | |
CN103882112B (en) | A kind of reagent and method predicting susceptibility of ankylosing spondylitis | |
CN103215259A (en) | Method and kit for predicting ankylosing spondylitis susceptibility | |
CN101676404A (en) | A method and agent for forecasting II type diabetes susceptibility using mitochondrion ND2 gene SNP | |
CA2461106C (en) | Compositions and methods for genetic analysis of polycystic kidney disease | |
CN103060433B (en) | Kit and method for predicating susceptibility to prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120523 |